The increasing use of technology for treating type 1 diabetes (T1D) has improved glycemic control; however, it hasn’t eliminated the risk for diabetic ketoacidosis (DKA). In fact, without early ...

NEW YORK, Dec. 10, 2025 /PRNewswire/ -- Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, announced the publication of a paper in the journal The Lancet ...

First-of-its-kind biowearables combine continuous glucose and ketone monitoring in a single sensor to support both daily diabetes management and help detect rising ketone levels that can lead to ...

The first international consensus framework for the use of continuous ketone monitoring in people with diabetes, published in The Lancet Diabetes & Endocrinology, calls development and use of ketone ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. From a straight technology standpoint, ...

Abbott has become the first company to secure a CE mark for a continuous glucose-ketone sensor for diabetic patients. Credit: Abbott via PR Newswire. · Medical Device Network · Abbott via PR Newswire.

BASEL, Switzerland, June 17, 2026 /PRNewswire/ -- FiberSense AG ("FiberSense") today announced that the FiberSense Continuous Glucose Monitoring (CGM) System has obtained CE marking under Regulation ...

The issuer is solely responsible for the content of this announcement. First-of-its-kind biowearables combine continuous glucose and ketone monitoring in a single sensor to support both daily diabetes ...